Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Costs of Long COVID
David Cutler
JAMA Health Forum (2022) Vol. 3, Iss. 5, pp. e221809-e221809
Open Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, et al.
JAMA (2023) Vol. 329, Iss. 22, pp. 1934-1934
Open Access | Times Cited: 531
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 164
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Carolyn T. Bramante, John B. Buse, David Liebovitz, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1119-1129
Open Access | Times Cited: 150
Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 82
Insights for COVID-19 in 2023
Francisco Javier Martín‐Sánchez, Manuel Martínez‐Sellés, José Molero, et al.
Revista Española de Quimioterapia (2022) Vol. 36, Iss. 2, pp. 114-124
Open Access | Times Cited: 69
Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 61
Post COVID-19 condition, work ability and occupational changes in a population-based cohort
Philipp Kerksieck, Tala Ballouz, Sarah R. Haile, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100671-100671
Open Access | Times Cited: 55
COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants
Ana Hernández‐Aceituno, Abigail García-Hernández, Eneko Larumbe‐Zabala
Infectious Diseases Now (2023) Vol. 53, Iss. 5, pp. 104688-104688
Open Access | Times Cited: 53
Understanding How Post–COVID-19 Condition Affects Adults and Health Care Systems
Gabrielle M. Katz, Katie Bach, Pavlos Bobos, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 7, pp. e231933-e231933
Open Access | Times Cited: 41
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis
Antonios M. Koumpias, David Schwartzman, Owen Fleming
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 54
Complexity and Challenges of the Clinical Diagnosis and Management of Long COVID
Ann M. O’Hare, Elizabeth K. Vig, Theodore J. Iwashyna, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2240332-e2240332
Open Access | Times Cited: 42
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review
Sophie Alice Müller, Lynda Isaaka, Rebekka Mumm, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 11, pp. e1713-e1724
Open Access | Times Cited: 32
Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness
Pratik P. Pandharipande, Shawniqua Williams Roberson, Fiona E. Harrison, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 726-738
Open Access | Times Cited: 30
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 26
A scoping review of ‘Pacing’ for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic
Nilihan E. M. Sanal-Hayes, Marie Mclaughlin, Lawrence D. Hayes, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
The impacts of Covid-19 absences on workers
Gopi Shah Goda, Evan Soltas
Journal of Public Economics (2023) Vol. 222, pp. 104889-104889
Open Access | Times Cited: 21
Long COVID research risks losing momentum – we need a moonshot
Lisa McCorkell, Michael J. Peluso
Nature (2023) Vol. 622, Iss. 7983, pp. 457-460
Open Access | Times Cited: 21
Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19
Amie Scott, Wajeeha Ansari, Farid Khan, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide
Jaleel Jerry G. Sweis, Fatima Alnaimat, Valeria Flórez Esparza, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 3, pp. 325-325
Open Access | Times Cited: 8
Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates
Fatemeh Saheb Sharif‐Askari, Hawra Ali Hussain Alsayed, Narjes Saheb Sharif‐Askari, et al.
Public Health (2024) Vol. 230, pp. 198-206
Closed Access | Times Cited: 8
Thematic analysis to explore patients’ experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives
Diana Rofail, Selin Somersan-Karakaya, Julia Y Choi, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e076992-e076992
Open Access | Times Cited: 7
What is Safe Long COVID Rehabilitation?
Jessica DeMars, Darren A. Brown, Ippokratis Angelidis, et al.
Journal of Occupational Rehabilitation (2022) Vol. 33, Iss. 2, pp. 227-230
Open Access | Times Cited: 36
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
Carolyn T. Bramante, John B. Buse, David Liebovitz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top